Virus safety of intravenous immunoglobulin: Future challenges

Patients with immunodeficiencies or some types of autoimmune diseases are dependent on safe therapy with intravenous immunoglobulins. State-of-the-art manufacturing processes provide a high safety standard by incorporating virus elimination procedures into the manufacturing process. Based on their m...

Descripción completa

Detalles Bibliográficos
Autores principales: Boschetti, Nicola, Stucki, Martin, Späth, Peter J., Kempf, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Humana Press 2005
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090396/
https://www.ncbi.nlm.nih.gov/pubmed/16391410
http://dx.doi.org/10.1385/CRIAI:29:3:333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090396/
https://www.ncbi.nlm.nih.gov/pubmed/16391410
http://dx.doi.org/10.1385/CRIAI:29:3:333

Ejemplares similares